Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Erwinase


Contraindicated
Lack of data in pregnant women

Not recommended
Lack of data
Erwinase :
Type Medicine Authorised
Originator Biotech (Kidrolase)
Agent BroadMed
Distributor BroadMed
Laboratory Porton Biopharma
Responsible Party Porton Biopharma Limited
Origin UK
Manufacturer Porton Biopharma
Origin UK
ATC L01XX02

Your comment will appear shortly after approval

Erwinase :

Revision Date : 01/09/2016


Effect Frequency
Abdominal pain Not known
Abnormal clotting factor Very Common
Alkaline phosphatase serum increased Common
ALT increased Common
Anaphylaxis Uncommon
Antithrombin III decreased Very Common
Arthritis reactive Very rare
AST increased Common
Bleeding Common
Blood bilirubin increased Common
Bronchospasm Uncommon
Chills Common
Cholesterol serum elevated Common
CNS depression Rare
Coagulation disorders Very Common
Coagulopathy Common
Coma Rare
Confusion Common
Convulsion Common
Diabetic ketoacidosis Rare
Diarrhoea (Diarrhea) Common
Dizziness Common
Dysphagia Rare
Dysphasia Rare
Dyspnoea (dyspnea) Common
Encephalopathy Rare
Erythema Common
Face oedema Common
Febrile neutropenia (Neutropenic fever) Very rare
Fibrinogen decreased Very Common
Flushing Not known
Grand mal convulsion Common
Haemorrhage Not known
Headache Common
Hepatic failure (Hepatic insufficiency) (Liver failure) Rare
Hepatomegaly Not known
Hepatotoxicity (liver toxicity) Common
Hyperammonaemia Not known
Hyperglycaemia Uncommon
Hyperlipidaemia Uncommon
Hypersensitivity reactions Common
Hypertension Not known
Hypofibrinogenaemia Common
Hypotension Not known
Hypoxia Uncommon
Infection Very rare
Injection site erythema Common
Injection site pain Common
Injection site reaction Common
Injection site swelling Common
Jaundice cholestatic (Cholestatic icterus) Not known
Laryngeal oedema Uncommon
Lethargy Common
Lip swelling Common
Lipase increased Common
Myalgia Very rare
Myocardial infarction Rare
Nausea Not known
Necrotizing pancreatitis Very rare
Neurotoxicity Common
Neutropenia Very rare
Pain Common
Pain in extremity (Pain in limb) Common
Pallor Common
Pancreatitis Rare
Pancreatitis acute Common
Pancreatitis haemorrhagic Very rare
Paresis Rare
Partial seizures Common
Posterior reversible leukoencephalopathy syndrome (PRES) Rare
Protein C deficiency Very Common
Protein S decreased Very Common
Pruritus Common
Purpura Common
Pyrexia Common
Respiratory arrest Uncommon
Rhinitis Uncommon
Sepsis (Systemic infection) (Sepsis state) Very rare
Serum amylase increased Common
Skin rash Common
Somnolence Common
Swelling of limb Common
Systemic allergic reaction Common
Thrombocytopenia (Thrombopenia) Very rare
Thrombosis Rare
Thrombotic events Common
Urticaria Common
Vomiting Not known

Different Units By MoH Code

Erwinase  MoH 11317 :
Form Powder for solution for injection
Packaging Bottle (Glass)
Package Size 5x3ml
Strength 10000IU
Public Price 4446519 L.L.
Stratum E2
NSSF ✘
Quarantine ✘
Reg. Number 53223/1
Submission date 2023
Registration Year 05/09/2023


NB : Reregistration in 2023 with same manufacturer

Price Comparison

● Country: Germany
● Package Size: 5
● Public Price: 5460.98 EUR ( 529,037,898.48 LBP )
● Pack size unit used: 5
● Cost/Unit: 1092,196 EUR ( 105,788,592.00 LBP )
● Pricing Date: 24/10/2020
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 5
● Public Price: 21850 AED ( 527,917,850.00 LBP )
● Pack size unit used: 5
● Cost/Unit: 4370 AED ( 105,583,570.00 LBP )
● Pharmacy Price: 19000 AED ( 459059000 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: The Netherlands
● Package Size: 5
● Public Price: 4356.1 EUR ( 422,001,543.60 LBP )
● Pack size unit used: 5
● Cost/Unit: 871,22 EUR ( 84,378,996.00 LBP )
● Pharmacy Price: 4349.1 EUR ( 421323411.6 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Greece
● Package Size: 5x3ml
● Public Price: 4273.83 EUR ( 414,031,555.08 LBP )
● Pack size unit used: 5
● Cost/Unit: 854,766 EUR ( 82,732,104.00 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/03/2019
● Type: Medicine Non Marketed

● Country: UK
● Package Size: 5
● Public Price: 3065 GBP ( 348,334,185.00 LBP )
● Pack size unit used: 5
● Cost/Unit: 613 GBP ( 69,666,837.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Argentina
● Package Size: 5
● Public Price: 494639.81 ARS ( 47,485,421.76 LBP )
● Pack size unit used: 5
● Cost/Unit: 98927,962 ARS ( 9,496,992.00 LBP )
● Reference: Ministerio de Salud
● Pricing Date: 13/05/2019
● Type: Medicine Authorised

● Country: Lebanon
● Form: Powder for solution for injection
● Package Size: 5x3ml
● Public Price: 4446519 LBP ( 4,446,519.00 LBP )
● Pack size unit used: 5
● Cost/Unit: 889303,8 LBP ( 889,303.00 LBP )
● Pricing Date: 13/06/2024

● Country: Portugal
● Package Size: 5
● Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
● Pricing Date: 22/04/2019

● Country: France
● Package Size: 5
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Acute lymphoblastic leukaemia : (Adults)
● Cost/Unit: 1092,196 EUR ( 105,788,592.00 LBP )
● Cost/Day: 2184,39 EUR ( 211,577,184.00 LBP )
● Cost/Month: 19659,51 EUR ( 1,904,485,284.00 LBP )
Acute lymphoblastic leukaemia : (Adults)
● Cost/Unit: 4370 AED ( 105,583,570.00 LBP )
● Cost/Day: 8740 AED ( 211,167,140.00 LBP )
● Cost/Month: 78660 AED ( 1,900,504,260.00 LBP )
Acute lymphoblastic leukaemia : (Adults)
● Cost/Unit: 871,22 EUR ( 84,378,996.00 LBP )
● Cost/Day: 1742,44 EUR ( 168,757,992.00 LBP )
● Cost/Month: 15681,96 EUR ( 1,519,112,556.00 LBP )
Acute lymphoblastic leukaemia : (Adults)
● Cost/Unit: 854,766 EUR ( 82,732,104.00 LBP )
● Cost/Day: 1709,53 EUR ( 165,561,084.00 LBP )
● Cost/Month: 15385,77 EUR ( 1,490,437,260.00 LBP )
Acute lymphoblastic leukaemia : (Adults)
● Cost/Unit: 613 GBP ( 69,666,837.00 LBP )
● Cost/Day: 1226 GBP ( 139,333,674.00 LBP )
● Cost/Month: 11034 GBP ( 1,254,003,066.00 LBP )
Acute lymphoblastic leukaemia : (Adults)
● Cost/Unit: 98927,962 ARS ( 9,496,992.00 LBP )
● Cost/Day: 197855,92 ARS ( 18,994,080.00 LBP )
● Cost/Month: 1780703,28 ARS ( 170,947,488.00 LBP )
Acute lymphoblastic leukaemia : (Adults)
● Cost/Unit: 889303,8 LBP ( 889,303.00 LBP )
● Cost/Day: 1778607,6 LBP ( 1,778,607.00 LBP )
● Cost/Month: 16007468,4 LBP ( 16,007,468.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info